Concurrent outbreaks of circulating vaccine-derived poliovirus types 1 and 2 affecting the Republic of the Philippines and Malaysia, 2019-2021.

@article{Snider2022ConcurrentOO,
  title={Concurrent outbreaks of circulating vaccine-derived poliovirus types 1 and 2 affecting the Republic of the Philippines and Malaysia, 2019-2021.},
  author={Cynthia J. Snider and Liliane Boualam and Graham F Tallis and Yoshihiro Takashima and Rabindra R. Abeyasinghe and Ying-Ru Lo and Varja Grabovac and Tigran Avagyan and Syeda Kanwal Aslam and Abu Obeida Eltayeb and Khin Devi Aung and Xiaojun Wang and Achyut Shrestha and Carla Ante-Orozco and Maria Wilda T. Silva and Nemia Lapastora-Sucaldito and Lea Necitas G Apostol and Muhammad Jikal and Waheed Miraj and Faisal Rashid Lodhi and Hyung Joon Kim and Norhayati Rusli and Bruce R. Thorley and Matthew B Kaye and Yorihiro Nishimura and Minetaro Arita and Jamiatul Aida Md. Sani and Christina Rundi and Keith Feldon},
  journal={Vaccine},
  year={2022}
}
View on PubMed
doi.org
1 Citations
Background Citations
1

One Citation

Response to back-to-back outbreaks of circulating vaccine-derived poliovirus type 2 in two nomadic pastoralist settlements in Oti Region, Ghana-2019

Three rounds of monovalent OPV vaccination campaigns for children under 5 years of age in the districts and region as well as countrywide IPV vaccination campaign for poliovirus type 2 naïve cohort were conducted to identify risk factors and implement control and preventive measures.

References

SHOWING 1-10 OF 13 REFERENCES

Update on Vaccine-Derived Poliovirus Outbreaks — Democratic Republic of the Congo and Horn of Africa, 2017–2018

For both countries, longer periods of surveillance are needed before interruption of cVDPV transmission can be inferred, and the primary challenge to interrupting transmission is the residence of >300,000 children in areas that are inaccessible for vaccination activities.

Are Circulating Type 2 Vaccine-derived Polioviruses (VDPVs) Genetically Distinguishable from Immunodeficiency-associated VDPVs?

The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study

Experience With Inactivated Polio Vaccine Introduction and the “Switch” From Trivalent to Bivalent Oral Polio Vaccine in the World Health Organization’s Western Pacific Region

Abstract The World Health Organization (WHO) Western Pacific Region (WPR) has maintained its polio-free status since 2000. The emergence of vaccine-derived polioviruses (VDPVs), however, remains a…

Progress Toward Polio Eradication — Worldwide, 2014–2015

Overcoming ongoing challenges to interruption of WPV transmission globally will require sustained programmatic enhancements, including improving the quality of supplementary immunization activities (SIAs) to interrupt transmission in Afghanistan and Pakistan and to prevent WPV exportation to polio-free countries.

Outbreak of Poliomyelitis in Hispaniola Associated with Circulating Type 1 Vaccine-Derived Poliovirus

An outbreak of paralytic poliomyelitis occurred in the Dominican Republic and Haiti during 2000–2001 and was associated with the circulation of a derivative of the type 1 OPV strain, probably originating from a single OPV dose given in 1998–1999.

Response to a Large Polio Outbreak in a Setting of Conflict — Middle East, 2013–2015

The concerted approach adopted in response to this outbreak could serve as a model for responding to polio outbreaks in settings of conflict and political instability.

Notes from the Field: Circulating Vaccine-Derived Poliovirus Type 1 and Outbreak Response — Papua New Guinea, 2018

Circulating Vaccine-Derived Poliovirus Type 1 and Outbreak Response — Papua New Guinea, 2018 Mathias Bauri, MPH, MBA1; Amanda L. Wilkinson, PhD2; Berry Ropa, MPH1; Keith Feldon, MPH3; Cynthia J.…

Progress Toward Poliomyelitis Eradication — Pakistan, January 2018–September 2019

Substantial changes are needed in Pakistan's polio eradication program, including continuing cross-border coordination with Afghanistan, gaining community trust, conducting high-quality vaccination campaigns, improving oversight of field activities, and improving managerial processes to unify eradication efforts.

Insidious reintroduction of wild poliovirus into Israel, 2013.

  • E. AnisE. Kopel I. Grotto
  • Medicine
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
  • 2013
Israel was certified as polio-free country in June 2002, but wild-type polio virus ₁ (WPV₁) was isolated initially from routine sewage samples collected between 7 and 13 April 2013 in two cities in the Southern district, and WPV-specific analysis of samples indicated WPV⁁ introduction into that area in early February 2013.